Oxygenta Pharmaceutical Ltd - Draft Letter of Offer
15 Oct 2024
Mark Corporate Advisors Pvt Ltd. ("Manager to the Offer") has submitted to BSE a copy of Draft Letter of Offer for the attention of the eligible equity shareholders of Oxygenta Pharmaceutical Ltd ("the Company").
Source:
BSE India